Pitcairn’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,669
| Closed | -$1M | – | 706 |
|
|
2023
Q3 | $1M | Buy |
8,669
+718
| +9% | +$83.1K | 0.08% | 209 |
|
|
2023
Q2 | $818K | Sell |
7,951
-68
| -0.8% | -$6.99K | 0.07% | 241 |
|
|
2023
Q1 | $875K | Sell |
8,019
-10,598
| -57% | -$1.16M | 0.08% | 221 |
|
|
2022
Q4 | $2.12M | Sell |
18,617
-88
| -0.5% | -$10K | 0.21% | 95 |
|
|
2022
Q3 | $1.16M | Sell |
18,705
-47
| -0.3% | -$2.91K | 0.13% | 154 |
|
|
2022
Q2 | $1.5M | Buy |
18,752
+9
| +0% | +$718 | 0.16% | 118 |
|
|
2022
Q1 | $1.97M | Buy |
18,743
+98
| +0.5% | +$10.3K | 0.17% | 106 |
|
|
2021
Q4 | $2.01M | Sell |
18,645
-409
| -2% | -$44.1K | 0.13% | 114 |
|
|
2021
Q3 | $2.09M | Sell |
19,054
-198
| -1% | -$21.7K | 0.14% | 100 |
|
|
2021
Q2 | $1.8M | Sell |
19,252
-499
| -3% | -$46.7K | 0.12% | 120 |
|
|
2021
Q1 | $1.82M | Buy |
19,751
+5,774
| +41% | +$531K | 0.13% | 115 |
|
|
2020
Q4 | $1.02M | Buy |
13,977
+102
| +0.7% | +$7.47K | 0.08% | 173 |
|
|
2020
Q3 | $1.08M | Sell |
13,875
-1,169
| -8% | -$90.7K | 0.09% | 140 |
|
|
2020
Q2 | $837K | Sell |
15,044
-1,124
| -7% | -$62.5K | 0.08% | 152 |
|
|
2020
Q1 | $479K | Buy |
16,168
+1,344
| +9% | +$39.8K | 0.06% | 207 |
|
|
2019
Q4 | $536K | Sell |
14,824
-322
| -2% | -$11.6K | 0.05% | 245 |
|
|
2019
Q3 | $412K | Sell |
15,146
-1,043
| -6% | -$28.4K | 0.04% | 280 |
|
|
2019
Q2 | $390K | Buy |
16,189
+22
| +0.1% | +$530 | 0.04% | 298 |
|
|
2019
Q1 | $427K | Buy |
+16,167
| New | +$427K | 0.05% | 256 |
|
|
2018
Q4 | – | Sell |
-14,915
| Closed | -$292K | – | 563 |
|
|
2018
Q3 | $292K | Buy |
+14,915
| New | +$292K | 0.03% | 410 |
|